SCHEMBL18044448

SCHEMBL18044448

O=C(O)c1ccc(C(=O)c2c(OCCOCCOCCOCCOCCOCCO)ccc(F)c2F)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RARB P10826 4/20 0.40
▸ ALDH1A1 P00352 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ PTK2B Q14289 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ BCL9 O00512 1/20 0.37
▸ CTNNB1 P35222 1/20 0.37
▸ PKM P14618 1/20 0.37
▸ MRGPRX4 Q96LA9 1/20 0.36
▸ LMNA P02545 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ SRD5A2 P31213 2/20 0.35
▸ RARG P13631 2/20 0.35
▸ RARA P10276 1/20 0.35
▸ POLB P06746 1/20 0.34
▸ CASP6 P55212 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ TTR P02766 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16690678 1.00 RARB (0.40) RARBALDH1A1KMT2APTK2BGAA
SCHEMBL20709028 0.92 GAA (0.44) RARBGAABCL9CTNNB1PKM
SCHEMBL18151908 0.89 RARB (0.46) RARBALDH1A1KMT2APTK2BLMNA
SCHEMBL18499050 0.89 RARB (0.40) RARBALDH1A1KMT2APTK2BLMNA
SCHEMBL18044460 0.89 RARB (0.40) RARBALDH1A1KMT2APTK2BLMNA
SCHEMBL18151941 0.89 RARB (0.40) RARBALDH1A1KMT2APTK2BLMNA
SCHEMBL18044474 0.86 MAPT (0.43) ALDH1A1KMT2ABCL9CTNNB1LMNA
SCHEMBL18044486 0.86 MAPT (0.43) ALDH1A1KMT2ABCL9CTNNB1LMNA
SCHEMBL20709025 0.78 MAPT (0.44) ALDH1A1KMT2AGAABCL9CTNNB1
SCHEMBL18044471 0.78 MAPT (0.44) ALDH1A1KMT2ALMNAHTTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3067351-B1 COMPOUND HAVING HIGHER INHIBITION OF PROTEIN KINASE G ACTIVITY AND PREPARATION METHOD THEREFOR JENKEM TECH CO LTD TIANJIN (CN) 2019-02-06 — — EP disclosed
US-9925171-B2 Compound having higher inhibitory activity on protein kinase G and preparation method thereof Jenkem Technology Co., Ltd., (Tianjin) (CN) 2018-03-27 — — US disclosed
US-9925171-B2 Compound having higher inhibitory activity on protein kinase G and preparation method thereof Jenkem Technology Co., Ltd., (Tianjin) (CN) 2018-03-27 — — US disclosed
US-20170119736-A1 COMPOUND HAVING HIGHER INHIBITORY ACTIVITY ON PROTEIN KINASE G AND PREPARATION METHOD THEREOF Jenkem Technology Co., Ltd., (Tianjin) (CN) 2017-05-04 — — US disclosed
US-20170119736-A1 COMPOUND HAVING HIGHER INHIBITORY ACTIVITY ON PROTEIN KINASE G AND PREPARATION METHOD THEREOF Jenkem Technology Co., Ltd., (Tianjin) (CN) 2017-05-04 — — US disclosed
US-9567319-B2 Compound having higher inhibitory activity on protein kinase G and preparation method thereof JENKEM TECHNOLOGY CO. LTD., (TIANJIN) (CN) 2017-02-14 — — US disclosed
US-9567319-B2 Compound having higher inhibitory activity on protein kinase G and preparation method thereof JENKEM TECHNOLOGY CO. LTD., (TIANJIN) (CN) 2017-02-14 — — US disclosed
US-20160304501-A1 COMPOUND HAVING HIGHER INHIBITORY ACTIVITY ON PROTEIN KINASE G AND PREPARATION METHOD THEREOF Jenkem Technology Co., Ltd., (Tianjin) (CN) 2016-10-20 — — US disclosed
US-20160304501-A1 COMPOUND HAVING HIGHER INHIBITORY ACTIVITY ON PROTEIN KINASE G AND PREPARATION METHOD THEREOF Jenkem Technology Co., Ltd., (Tianjin) (CN) 2016-10-20 — — US disclosed
EP-3067351-A1 COMPOUND HAVING HIGHER INHIBITION OF PROTEIN KINASE G ACTIVITY AND PREPARATION METHOD THEREFOR Jenkem Technology Co. Ltd. (Tianjin) (CN) 2016-09-14 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160304501-A1 COMPOUND HAVING HIGHER INHIBITORY ACTIVITY ON PROTEIN KINASE G AND PREPARATION METHOD THEREOF PRKCG, PRKG2, PKN3 RARB 4527/4885ALDH1A1 4122/4885KMT2A 1940/4885
US-20170119736-A1 COMPOUND HAVING HIGHER INHIBITORY ACTIVITY ON PROTEIN KINASE G AND PREPARATION METHOD THEREOF PRKCG, PRKG2, PKN3 RARB 4527/4885ALDH1A1 4122/4885KMT2A 1940/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback